Financial Synergies Wealth Advisors, Inc. Denali Therapeutics Inc. Transaction History
Financial Synergies Wealth Advisors, Inc.
- $742 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
220Shares Held
115MCall Options Held
142KPut Options Held
90.3K-
Baillie Gifford & CO13.8MShares$332 Million0.25% of portfolio
-
Black Rock Inc. New York, NY12.2MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$264 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.27MShares$199 Million0.03% of portfolio
-
State Street Corp Boston, MA6.32MShares$152 Million0.01% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.23B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...